|
02 tolerance
|
|
1,1-dimethylhydrazine
|
|
133Xe
|
|
(18)F-deoxyglucose
|
|
2.36 ATA
|
|
2,3 DPG concentration
|
|
28 days
|
|
2-D cardiac echo image bubble detection
|
|
2-D echo-imaging
|
|
332ND FIGHTER GROUP
|
|
3,4-dihydroxyphenylacetic acid
|
|
3,4-Dihydroxyphenylacetic Acid/metabolism Amiloride/analogs & derivatives Amiloride/pharmacology Animals Calcium/metabolism* Corpus Striatum/metabolism* Dopamine/secretion* Helium/antagonists & inhibitors Helium/pharmacology* High Pressure Neurological Syndrome/metabolism* Male Ouabain/antagonists & inhibitors Ouabain/pharmacology* Potassium/metabolism Rats Rats, Inbred Strains Substances: 3,4-Dihydroxyphenylacetic Acid 3',4'-dichlorobenzamil Amiloride Dopamine Ouabain Potassium Helium Calcium
|
|
3,4-Dihydroxyphenylacetic Acid/metabolism Animals Atmospheric Pressure* Calcium/physiology Chromatography, High Pressure Liquid Corpus Striatum/metabolism* Dopamine/metabolism* Helium/pharmacology* Male Nitrogen/pharmacology* Rats Rats, Inbred Strains Substances: 3,4-Dihydroxyphenylacetic Acid Dopamine Helium Calcium Nitrogen
|
|
3-D ecoSCOPE
|
|
3HB volumetric infusion pump
|
|
[3h]GABA
|
|
3-HYHDROXYBUTIRATE
|
|
41Ar
|
|
477TH BOMBARDMENT GROUP
|
|
5 ATA
|
